TapewireFind a company

person · Reporting owner

Nelson Lisa M

Disclosed activity across 2 companies

Tapewire entity
73027
SEC CIK
0001865864

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
EQUIFAX INCEFX · Entity 3235EVP, President InternationalFebruary 11, 2025February 13, 2025
JACK HENRY & ASSOCIATES INCJKHY · Entity 3466DirectorNovember 17, 2025November 18, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

EQUIFAX INC

Report date February 11, 2025 · Filed February 13, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect13,653 Last balance in matching sequence After 2025-02-12 transaction · row 3 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rows

Row 1 · 2025-02-11 · Grant · Acquired 2,203 · Balance 15,886

F1: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Row 2 · 2025-02-11 · Tax withholding · Disposed 1,681 · Balance 14,205

F1: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Row 3 · 2025-02-12 · Sale · Disposed 552 · Balance 13,653

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/27/2024.

F1: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Filing footnotes · ownership attribution and instrument terms

F1: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/27/2024.

JACK HENRY & ASSOCIATES INC

Report date November 17, 2025 · Filed November 18, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect1,220 Reported balance After 2025-11-17 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2025-11-17 · Grant · Acquired 1,220 · Balance 1,220

F1: Each restricted stock unit is the economic equivalent of one share of JKHY common stock and represents a contingent right to receive one share of JKHY common stock or, at the Issuer's option, the cash value thereof.

F2: On November 17, 2025, the reporting person was granted restricted stock units, vesting in full on the earlier of (1) the day before the Issuer's 2026 Annual Meeting of Stockholders or (2) the first anniversary of the grant date.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit is the economic equivalent of one share of JKHY common stock and represents a contingent right to receive one share of JKHY common stock or, at the Issuer's option, the cash value thereof.

F2: On November 17, 2025, the reporting person was granted restricted stock units, vesting in full on the earlier of (1) the day before the Issuer's 2026 Annual Meeting of Stockholders or (2) the first anniversary of the grant date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
November 17, 2025 Filed Nov 18, 2025 21:24 UTC JACK HENRY & ASSOCIATES INC JKHY · Entity 3466 GrantRestricted Stock Units · Derivative 1,220 $0.00 $0.00
Disclosure

SEC source: 0000779152-25-000131 · wk-form4_1763501057.xml · derivative · entry 1

Nelson Lisa M · CIK 0001865864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,220

Underlying: Common Stock · 1,220 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of JKHY common stock and represents a contingent right to receive one share of JKHY common stock or, at the Issuer's option, the cash value thereof.

F2 · derivative.exercise_date: On November 17, 2025, the reporting person was granted restricted stock units, vesting in full on the earlier of (1) the day before the Issuer's 2026 Annual Meeting of Stockholders or (2) the first anniversary of the grant date.

F2 · derivative.expiration_date: On November 17, 2025, the reporting person was granted restricted stock units, vesting in full on the earlier of (1) the day before the Issuer's 2026 Annual Meeting of Stockholders or (2) the first anniversary of the grant date.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:34 UTC JACK HENRY & ASSOCIATES INC JKHY · Entity 3466 Exercise / conversionRestricted Stock Units · Derivative 1,159 $0.00 $0.00
Disclosure

SEC source: 0000779152-25-000119 · wk-form4_1763062478.xml · derivative · entry 2

Nelson Lisa M · CIK 0001865864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,159 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of JKHY common stock and represents a contingent right to receive one share of JKHY common stock or, at the Issuer's option, the cash value thereof.

F2 · derivative.exercise_date: On November 15, 2024, the reporting person was granted restricted stock units, vesting in full on the earlier of (1) the day before the Issuer's 2025 Annual Meeting of Stockholders or (2) the first anniversary of the grant date.

F2 · derivative.expiration_date: On November 15, 2024, the reporting person was granted restricted stock units, vesting in full on the earlier of (1) the day before the Issuer's 2025 Annual Meeting of Stockholders or (2) the first anniversary of the grant date.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:34 UTC JACK HENRY & ASSOCIATES INC JKHY · Entity 3466 Exercise / conversionCommon Stock 1,159 $0.00 $0.00
Disclosure

SEC source: 0000779152-25-000119 · wk-form4_1763062478.xml · nonDerivative · entry 1

Nelson Lisa M · CIK 0001865864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,524

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 12, 2025 Filed Feb 13, 2025 21:13 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 552 $248.18 $136,995.36
Disclosure

SEC source: 0001225208-25-001648 · doc4.xml · nonDerivative · entry 3

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,653

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/27/2024.

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 11, 2025 Filed Feb 13, 2025 21:13 UTC EQUIFAX INC EFX · Entity 3235 Tax withholdingCommon Stock 1,681 $253.00 $425,293.00
Disclosure

SEC source: 0001225208-25-001648 · doc4.xml · nonDerivative · entry 2

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,205

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 11, 2025 Filed Feb 13, 2025 21:13 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 2,203 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-001648 · doc4.xml · nonDerivative · entry 1

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,886

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 21:15 UTC EQUIFAX INC EFX · Entity 3235 GrantStock Option/Right to Buy · Derivative 6,352 $0.00 Strike: $252.90 $0.00
Disclosure

SEC source: 0001225208-25-001586 · doc4.xml · derivative · entry 2

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,352

Underlying: Common Stock · 6,352 shares

Expires 2035-02-10

F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 10, 2026.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 21:15 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 1,978 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-001586 · doc4.xml · nonDerivative · entry 1

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,683

F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2028.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 26, 2024 Filed Nov 27, 2024 21:14 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 551 $260.39 $143,474.89
Disclosure

SEC source: 0001225208-24-010250 · doc4.xml · nonDerivative · entry 1

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,697

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/27/2024.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 15, 2024 Filed Nov 19, 2024 19:59 UTC JACK HENRY & ASSOCIATES INC JKHY · Entity 3466 GrantRestricted Stock Units · Derivative 1,159 $0.00 $0.00
Disclosure

SEC source: 0000779152-24-000145 · wk-form4_1732046350.xml · derivative · entry 1

Nelson Lisa M · CIK 0001865864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,159

Underlying: Common Stock · 1,159 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of JKHY common stock and represents a contingent right to receive one share of JKHY common stock or, at the Issuer's option, the cash value thereof.

F2 · derivative.exercise_date: On November 15, 2024, the reporting person was granted restricted stock units, vesting in full on the earlier of (1) the day before the Issuer's 2025 Annual Meeting of Stockholders or (2) the first anniversary of the grant date

F2 · derivative.expiration_date: On November 15, 2024, the reporting person was granted restricted stock units, vesting in full on the earlier of (1) the day before the Issuer's 2025 Annual Meeting of Stockholders or (2) the first anniversary of the grant date

Read SEC document
November 11, 2024 Filed Nov 13, 2024 21:49 UTC JACK HENRY & ASSOCIATES INC JKHY · Entity 3466 Exercise / conversionRestricted Stock Units · Derivative 365 $0.00 $0.00
Disclosure

SEC source: 0000779152-24-000124 · wk-form4_1731534566.xml · derivative · entry 2

Nelson Lisa M · CIK 0001865864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 365 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of JKHY common stock and represents a contingent right to receive one share of JKHY common stock or, at the Issuer's option, the cash value thereof.

F2 · derivative.exercise_date: On July 23, 2024, the reporting person was granted restricted stock units, vesting in full on the the day before the Issuer's 2024 Annual Meeting of Stockholders.

F2 · derivative.expiration_date: On July 23, 2024, the reporting person was granted restricted stock units, vesting in full on the the day before the Issuer's 2024 Annual Meeting of Stockholders.

Read SEC document
November 11, 2024 Filed Nov 13, 2024 21:49 UTC JACK HENRY & ASSOCIATES INC JKHY · Entity 3466 Exercise / conversionCommon Stock 365 Not disclosed Not disclosed
Disclosure

SEC source: 0000779152-24-000124 · wk-form4_1731534566.xml · nonDerivative · entry 1

Nelson Lisa M · CIK 0001865864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 365

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit is the economic equivalent of one share of JKHY common stock and represents a contingent right to receive one share of JKHY common stock or, at the Issuer's option, the cash value thereof.

Read SEC document
July 23, 2024 Filed Jul 25, 2024 20:21 UTC JACK HENRY & ASSOCIATES INC JKHY · Entity 3466 GrantRestricted Stock Units · Derivative 365 $0.00 $0.00
Disclosure

SEC source: 0000779152-24-000058 · wk-form4_1721938882.xml · derivative · entry 1

Nelson Lisa M · CIK 0001865864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 365

Underlying: Common Stock · 365 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of JKHY common stock and represents a contingent right to receive one share of JKHY common stock or, at the Issuer's option, the cash value thereof.

F2 · derivative.exercise_date: On July 23, 2024, the reporting person was granted restricted stock units, vesting in full on the the day before the Issuer's 2024 Annual Meeting of Stockholders.

F2 · derivative.expiration_date: On July 23, 2024, the reporting person was granted restricted stock units, vesting in full on the the day before the Issuer's 2024 Annual Meeting of Stockholders.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 21:50 UTC EQUIFAX INC EFX · Entity 3235 Tax withholdingCommon Stock 1,402 $255.78 $358,603.56
Disclosure

SEC source: 0001225208-24-002072 · doc4.xml · nonDerivative · entry 2

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,223

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 21:50 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 2,135 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002072 · doc4.xml · nonDerivative · entry 1

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,625

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 09, 2024 Filed Feb 13, 2024 21:10 UTC EQUIFAX INC EFX · Entity 3235 GrantStock Option/Right to Buy · Derivative 6,452 $0.00 Strike: $249.18 $0.00
Disclosure

SEC source: 0001225208-24-001936 · doc4.xml · derivative · entry 2

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,452

Underlying: Common Stock · 6,452 shares

Expires 2034-02-09

F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 9, 2025.

Read SEC document
February 09, 2024 Filed Feb 13, 2024 21:10 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 2,007 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-001936 · doc4.xml · nonDerivative · entry 1

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,490

F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 9, 2027.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 21, 2023 Filed Feb 23, 2023 21:08 UTC EQUIFAX INC EFX · Entity 3235 Tax withholdingCommon Stock 391 $203.81 $79,689.71
Disclosure

SEC source: 0001225208-23-002663 · doc4.xml · nonDerivative · entry 1

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,447

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:14 UTC EQUIFAX INC EFX · Entity 3235 GrantStock Option/Right to Buy · Derivative 7,730 $0.00 Strike: $206.16 $0.00
Disclosure

SEC source: 0001225208-23-001892 · doc4.xml · derivative · entry 2

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,730

Underlying: Common Stock · 7,730 shares

Expires 2033-02-10

F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 10, 2024.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:14 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 2,426 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-001892 · doc4.xml · nonDerivative · entry 1

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,838

F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2026.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 03, 2022 Filed Nov 7, 2022 21:06 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 40 $160.23 $6,409.14
Disclosure

SEC source: 0001225208-22-011404 · doc4.xml · nonDerivative · entry 3

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,406

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/5/2022.

F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $160.02 to $160.72, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 03, 2022 Filed Nov 7, 2022 21:06 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 39 $159.50 $6,220.50
Disclosure

SEC source: 0001225208-22-011404 · doc4.xml · nonDerivative · entry 2

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,446

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/5/2022.

F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $159.01 to $159.895, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 03, 2022 Filed Nov 7, 2022 21:06 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 21 $158.51 $3,328.67
Disclosure

SEC source: 0001225208-22-011404 · doc4.xml · nonDerivative · entry 1

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,485

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/5/2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $158.01 to $158.915, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 01, 2022 Filed Nov 3, 2022 20:09 UTC EQUIFAX INC EFX · Entity 3235 Tax withholdingCommon Stock 84 $168.99 $14,195.16
Disclosure

SEC source: 0001225208-22-011322 · doc4.xml · nonDerivative · entry 1

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,506

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
October 26, 2022 Filed Oct 28, 2022 20:12 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 257 $164.82 $42,359.10
Disclosure

SEC source: 0001225208-22-011213 · doc4.xml · nonDerivative · entry 5

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,590

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/5/2022.

F6 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $164.36 to $165.18, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
October 26, 2022 Filed Oct 28, 2022 20:12 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 194 $166.82 $32,362.92
Disclosure

SEC source: 0001225208-22-011213 · doc4.xml · nonDerivative · entry 4

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,847

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/5/2022.

F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $166.50 to $166.98, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
October 26, 2022 Filed Oct 28, 2022 20:12 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 112 $165.71 $18,559.50
Disclosure

SEC source: 0001225208-22-011213 · doc4.xml · nonDerivative · entry 3

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,041

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/5/2022.

F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $165.45 to $165.87, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
October 26, 2022 Filed Oct 28, 2022 20:12 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 61 $162.60 $9,918.87
Disclosure

SEC source: 0001225208-22-011213 · doc4.xml · nonDerivative · entry 2

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,153

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/5/2022.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $162.59 to $163.03, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
October 26, 2022 Filed Oct 28, 2022 20:12 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 60 $167.61 $10,056.60
Disclosure

SEC source: 0001225208-22-011213 · doc4.xml · nonDerivative · entry 1

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,214

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/5/2022.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
August 01, 2022 Filed Aug 3, 2022 20:13 UTC EQUIFAX INC EFX · Entity 3235 Tax withholdingCommon Stock 754 $210.78 $158,928.12
Disclosure

SEC source: 0001225208-22-009173 · doc4.xml · nonDerivative · entry 1

Nelson Lisa M · CIK 0001865864 · EVP, President International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,266

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 22, 2022 Filed Feb 24, 2022 21:11 UTC EQUIFAX INC EFX · Entity 3235 Tax withholdingCommon Stock 754 $212.24 $160,028.96
Disclosure

SEC source: 0001225208-22-003267 · doc4.xml · nonDerivative · entry 1

Nelson Lisa M · CIK 0001865864 · President-International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,000

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 22:34 UTC EQUIFAX INC EFX · Entity 3235 GrantStock Option/Right to Buy · Derivative 5,772 $0.00 Strike: $225.00 $0.00
Disclosure

SEC source: 0001225208-22-002193 · doc4.xml · derivative · entry 2

Nelson Lisa M · CIK 0001865864 · President-International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,772

Underlying: Common Stock · 5,772 shares

Expires 2032-02-11

F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/11/2023.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 22:34 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 1,445 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002193 · doc4.xml · nonDerivative · entry 1

Nelson Lisa M · CIK 0001865864 · President-International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,754

F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/11/2025.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.